Work

Low- Versus Moderate-Dose Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Disease in Sub-Saharan Africa: Final Results of a Randomized Controlled Trial, Sprint Trial

Year: 2020

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-142896

Authors: Shehu Umar Abdullahi, Surayya M. Sunusi, Mohammed Sani Abba, Saifuddeen Sani, Aisha Galadanci, Hauwa Inuwa, Binta W. Jibir, Brittany Covert Greene, Adetola A. Kassim, Lori C. Jordan, Muktar Aliyu, Mark Rodeghier, Awwal Musa Borodo, Bilya Sani Musa, Habu Abdu, Michael R. DeBaun

Institutions: Aminu Kano Teaching Hospital, Bayero University Kano, Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096756031

FWCI: 0.519

Cites:

Cited by: 5

Related to: 10